Please attach a copy of your grant award letter/AN paperwork that includes details of awarded funding. Where there is a CASE partner please also attach confirmation of the award from the partner.
Projects cannot be advertised without these and permission from the relevant RIN Project Officer that you have been liaising with.
(i) Incidence of inflammatory polyarthritis in polymyalgia rheumatica: a population-based cohort study.
Yates M, Kotecha J, Watts RA, Luben R, Khaw KT, MacGregor AJ.
Ann Rheum Dis. 2018 Oct 26. pii: annrheumdis-2018-214386.
(ii) Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice.
Yates M, Watts RA, Swords F, MacGregor AJ.
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):1-2
(iii) The association of vascular risk factors with visual loss in giant cell arteritis.
Yates M, MacGregor AJ, Robson J, Craven A, Merkel PA, Luqmani RA, Watts RA.
Rheumatology (Oxford). 2017 Apr 1;56(4):524-528.
(iv) The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population.
Yates M, Graham K, Watts RA, MacGregor AJ.
BMC Musculoskelet Disord. 2016 Jul 15;17:285.
(v) Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Yates M, Loke YK, Watts RA, MacGregor AJ.
Clin Rheumatol. 2014 Feb;33(2):227-36.